Infectious Disease Control
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet
* Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial * Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy pot...
2021-02-01 14:00
3847
Taiwan's innovative technology allows for germ eliminating fabric by making use of semiconductor mechanics
TAIPEI, Jan. 29, 2021 /PRNewswire/ -- With COVID-19 becoming more deadly with mutations and secondary infections becoming more frequent,people have shifted our focus from usingprotective masks to rushing and cutting lines to get the new vaccine.A company has created a textile that is about to be ...
2021-01-29 21:00
3408
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals
TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-01-28 22:03
5907
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged
VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. T...
2021-01-28 21:46
5706
SC Johnson Partners With Habitat for Humanity to Provide Access to Housing, Clean Water and Sanitation across Asia Pacific
RACINE, Wis., Jan. 28, 2021 /PRNewswire/ -- In response to the unprecedented impact of the COVID-19 pandemic on underserved communities, SC Johnson is teaming with Habitat for Humanity to provide access to housing and proper water, sanitation and hygiene (WASH) facilities for hundreds of families...
2021-01-28 14:41
2540
Tencent Cloud raises the bar of crowd management through intelligent cloud solutions and AI technology suitable for all organizations
BANGKOK, Jan. 28, 2021 /PRNewswire/ -- Tencent Cloud, the cloud business of Tencent, today introduces its intelligent cloud solutions and artificial intelligence (AI) technology that could be leveraged for crowd management in the Southeast Asia amid the pandemic. The company offers a suite of solu...
2021-01-28 14:00
2120
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies
Sub-group analysis shows three-day earlier discharge from hospital in low-risk patients hospitalized with COVID-19 KUWAIT CITY, Jan. 28, 2021 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to ...
2021-01-28 03:57
2982
Bill and Melinda Gates Release 2021 Annual Letter: "The Year Global Health Went Local"
SEATTLE, Jan. 27, 2021 /PRNewswire/ -- Today, Bill and Melinda Gates share their 2021 Annual Letter, "The Year Global Health Went Local." In this year's letter, Bill and Melinda reflect on the worldwide impact of COVID-19 and the global collaboration and scientific innovation fueling one of the la...
2021-01-27 16:00
2371
CGTN: Hand in Hand: China calls for multilateralism to tackle global crises
BEIJING, Jan. 26, 2021 /PRNewswire/ -- Against the backdrop of a pandemic that has taken tolls on global public health and put the world economy in deep recession, the world in 2020 left many living with fear and uncertainty with the situation further worsening due to other emerging challenges. ...
2021-01-26 03:18
2863
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program
VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is ple...
2021-01-25 21:00
3713
Dada Group secures necessities supply in Shijiazhuang during COVID-19 outbreak -- Chinese National TV Reported
SHANGHAI, Jan. 24, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("Dada" or the "Company"),China's leading local on-demand delivery and retail platform, is working with retailers and brands to provide safe, contactless on-demand delivery service inShijiazhuang, Hebei Province, to combat with the...
2021-01-25 11:29
4242
New Zealand team creates world-first innovation in the fight against Coronavirus
AUCKLAND, New Zealand, Jan. 22, 2021 /PRNewswire/ -- Datamine, a New Zealand based AI company, has createdëlarm: a personal early warning indicator for viral infection, includingCoronavirus. The ëlarm system overcomes what is arguably our greatest obstacle – viral spread by asymptomatic people wh...
2021-01-23 00:41
3262
Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021
TOKYO, Jan. 21, 2021 /PRNewswire/ -- With the approach of World Leprosy Day on
January 31, 2021, Sasakawa Leprosy (Hansen's Disease) Initiative has created a
number of opportunities to amplify the voices of persons affected by leprosy
and highlight the issues they face.
2021-01-21 22:00
1964
Shanghai Electric Strengthens Environmental, Social, and Corporate Governance for Dubai MBR Solar Park Project
SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- Shanghai Electric Group ("Shanghai Electric" or "the Company") has strengthened its environmental, social, and corporate governance for the Phase 5 project forDubai's 900MW Mohammed bin Rashid Al Maktoum Solar Park (MBR Solar Park), winning praise from Shua...
2021-01-21 16:13
7696
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals inJapan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now available to patie...
2021-01-21 16:00
2235
Seegene to advance business in Latin America in the New Year
SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...
2021-01-21 07:56
2331
ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage
LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered a ...
2021-01-21 06:00
2561
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization
BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...
2021-01-19 16:00
1422
Air France Awarded 4-Star "COVID-19 Airline Safety Rating" By Skytrax
PARIS, Jan. 15, 2021 /PRNewswire/ -- Air France has been certified with the COVID-19 Airline Safety Rating following the global audit conducted by the international air transport rating agency Skytrax. This audit, carried out in December 2020 on several Air France medium and long-haul flights, eva...
2021-01-15 12:24
3091
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization
- Ortho's VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Ortho's latest COVID-19 solution can run up to 130 tests ...
2021-01-13 03:13
1623
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 302 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4434
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3617
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3590
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3387